- HOME
- AUTOMOTIVE
- BANKING & FINANCE
- BUSINESS & GOVERNMENT
- CHEMICALS
- COMPUTING & ELECTRONICS
- CONSUMER & RETAIL
Find information products concerning the global biotech and pharmaceutical industries.
Browse and buy business information studies, management reports and market research.
| Wholesale of pharmaceutical and medical goods (Russia) - Industry ReportPlimsoll's Wholesale of pharmaceutical and medical goods (Russia) - Industry Report analysis is the most definitive and accurate study of the Wholesale of pharmaceutical and medical goods (Russia) - Industry... | May 2013 | £565 |
| Wholesale of pharmaceutical goods (Germany) - Industry ReportPlimsoll's Wholesale of pharmaceutical goods (Germany) analysis is the most definitive and accurate study of the Wholesale of pharmaceutical goods (Germany) sector in 2013. The report (compiled in German language) is... | May 2013 | £500 |
| Medical Dressings - Top 5 European Markets PackageThis market research report package offers a perspective on the actual market situation, trends and future outlook for medical dressings in the top 5 European countries. The studies provide essential... | May 2013 | £1,595 |
| Medical Dressings - Top 5 Asian Markets PackageThis market research report package offers a perspective on the actual market situation, trends and future outlook for medical dressings in the top 5 Asian countries. The studies provide essential... | May 2013 | £1,595 |
| OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs... | Apr 2013 | £3,850 |
| OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Limited to the lungs it... | Apr 2013 | £3,850 |
| Pharmaceutical Market: India"Pharmaceutical Market: India, A Competitive Industry Analysis" by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. This... | May 2013 | £1,600 |
| Blood Disease Treatment Drugs Markets in ChinaChina's demand for blood treatment disease drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.... | May 2013 | £2,570 |
| Consensus Outlook: Prostate Cancer Competition intensifies in race to the topThe prostate cancer market has experienced substantial changes in the last five years with patent expiries of key compounds and approvals of new novel therapies. The launch of Zytiga (abiraterone... | Apr 2013 | £3,595 |
| MEMS Gyroscope Patent InvestigationUnderstanding the key players’ patent portfolios About 200 players are involved in MEMS gyroscope technologies, but the top 10 represent 63% of the patents filed! Panasonic and Murata lead the way. Both... | Apr 2013 | £5,055 |
| Pharmaceutical Industry in India - Porter's Five Forces Strategy AnalysisThe Indian pharmaceutical industry is one of the fast growing sectors of the Indian economy and has made rapid strides over the years. From being an import dependent industry in... | Jan 2011 | £110 |
| Bangladesh Pharmaceuticals and Healthcare Report Q12012BMI View: Economic growth will aid the development of Bangladesh's pharmaceutical and healthcare sectors as affordability levels increase and fiscal contributions towards healthcare service provision rise. However, due to Bangladesh's... | Jan 2012 | £755 |
| Global Animal Health Market Report2012 EditionAnimal health market mainly comprises of medicines, medicinal feed additives and vaccines and caters to both food producing and companion animals. Food producing animals are species for the production of... | Dec 2012 | £490 |
| Top 100 Global Pharmaceutical Manufacturers Industry AnalysisThe Global Top 100 Pharmaceutical Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels... | Aug 2011 | £820 |
| The Pharmaceutical Market - Philippines Summary BMI's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context.... | Jan 2013 | £810 |
| The Global Advanced Wound Care Market to 2017This report examines the market, product ranges and growth drivers, and provides market share data by company for major product sectors and growth forecasts to 2017. Also included are competitor... | Aug 2012 | £1,010 |
| Nutritional Supplements Market Report2012 EditionNutritional supplements include vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet. As health consciousness... | May 2012 | £510 |
| The Pharmaceutical Market - Pakistan Summary BMI's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context.... | Jan 2013 | £810 |
| Generic Competition, 2009 to 2013The impact of patent expiries on sales of major drugsThe period 2009–13 will see major companies facing very different degrees of exposure to the potential loss of revenue to generics. Eli Lilly, Pfizer, Bristol-Myers Squibb, Merck and Takeda all face the potential loss... | Apr 2009 | £995 |
| Sanofi-aventis: Pipeline, Products, Performance, PotentialPharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth,... | Sep 2007 | £595 |